Zobrazeno 1 - 10
of 19
pro vyhledávání: '"pathology [Dopaminergic Neurons]"'
Autor:
Laura Malz, Eva M Szego, Nadine Bernhardt, Angela Rösen-Wolff, Björn H Falkenburger, Hella Luksch
Publikováno v:
eLife 11, e81943 (2022). doi:10.7554/eLife.81943
Stimulator of interferon genes (STING) is activated after detection of cytoplasmic dsDNA by cGAS (cyclic GMP-AMP synthase) as part of the innate immunity defence against viral pathogens. STING binds TANK-binding kinase 1 (TBK1). TBK1 mutations are as
Autor:
Anke Van der Perren, Veerle Baekelandt, Björn H. Falkenburger, Lennart Höfs, Chris Van Den Haute, Eva M. Szegö
Publikováno v:
Experimental neurology 347, 113900 (2022). doi:10.1016/j.expneurol.2021.113900
Experimental neurology 347, 113900 (2022). doi:10.1016/j.expneurol.2021.113900
Published by Elsevier, Amsterdam[u.a.]
Published by Elsevier, Amsterdam[u.a.]
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d05b397acfc3516ae9446415578af5ec
Autor:
Yanina Dening, Theresa Straßl, Viktoria Ruf, Petra Dirscherl, Alexandra Chovsepian, Alicia Stievenard, Amit Khairnar, Felix Schmidt, Florian Giesert, Jochen Herms, Johannes Levin, Marianne Dieterich, Peter Falkai, Daniela Vogt Weisenhorn, Wolfgang Wurst, Armin Giese, Francisco Pan-Montojo
Publikováno v:
Sci. Rep. 12:21951 (2022)
Scientific reports 12(1), 21951 (2022). doi:10.1038/s41598-022-25790-2
Scientific reports 12(1), 21951 (2022). doi:10.1038/s41598-022-25790-2
Parkinson′s disease (PD) pathology progresses throughout the nervous system affecting numerous neuronal structures. It has been postulated that the progression of the pathology is based on a prion-like disease mechanism partly due to the seeding ef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06a1684d991f4a1f1cd6f04c1b9b3b07
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=67079
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=67079
Autor:
Andreas Kupsch, Jens K. Haumesser, Christoph van Riesen, Daniel Harnack, Johanna Kühn, Vadim V. Nikulin, Andrea A. Kühn, Franziska Pellegrini, Maximilian H. Beck, Wolf-Julian Neumann, Jennifer Altschüler
Publikováno v:
Experimental neurology 335, 113513-(2021). doi:10.1016/j.expneurol.2020.113513
Excessive beta activity has been shown in local field potential recordings from the cortico-basal ganglia loop of Parkinson's disease patients and in its various animal models. Recent evidence suggests that enhanced beta oscillations may play a centr
Autor:
Elisabeth Dinter, Björn H. Falkenburger, Theodora Saridaki, Leonie Diederichs, Heinz Reichmann
Publikováno v:
Translational Neurodegeneration
Translational Neurodegeneration, Vol 9, Iss 1, Pp 1-11 (2020)
Translational neurodegeneration 9(1), 43 (2020). doi:10.1186/s40035-020-00223-0
Translational Neurodegeneration, Vol 9, Iss 1, Pp 1-11 (2020)
Translational neurodegeneration 9(1), 43 (2020). doi:10.1186/s40035-020-00223-0
Parkinson’s disease (PD) is diagnosed when patients exhibit bradykinesia with tremor and/or rigidity, and when these symptoms respond to dopaminergic medications. Yet in the last years there was a greater recognition of additional aspects of the di
Publikováno v:
Experimental neurology 350, 113976 (2022). doi:10.1016/j.expneurol.2022.113976
Sleep disorders are integral to Parkinson's disease (PD). Insomnia, an inability to maintain stable sleep, affects most patients and is widely rated as one of the most debilitating facets of this disease. PD insomnia is often perceived as a multifact
Autor:
Sigrun Nestel, Silvia De Cicco, Vasiliki Panagiotakopoulou, Cong Yu, David C. Schöndorf, Michela Deleidi, Lukas Kristoffer Schwarz, Ivana Giunta, Oliver Bandmann, Thomas Gasser, Bernd Heimrich, Pascale Baden, Jan Pruszak, Gabriele Di Napoli, Marcus Keatinge, Alexander J. Whitworth, Alvaro Sanchez-Martinez, Dina Ivanyuk
Publikováno v:
Cell reports 23(10), 2976-2988 (2018). doi:10.1016/j.celrep.2018.05.009
While mitochondrial dysfunction is emerging as key in Parkinson's disease (PD), a central question remains whether mitochondria are actual disease drivers and whether boosting mitochondrial biogenesis and function ameliorates pathology. We address th
Publikováno v:
Cells 10(12), 3436 (2021). doi:10.3390/cells10123436 special issue: "Mitochondrial Functions in Stem Cells"
Cells
Cells, Vol 10, Iss 3436, p 3436 (2021)
Cells
Cells, Vol 10, Iss 3436, p 3436 (2021)
Established disease models have helped unravel the mechanistic underpinnings of pathological phenotypes in Parkinson’s disease (PD), the second most common neurodegenerative disorder. However, these discoveries have been limited to relatively simpl
Autor:
Giovanna Ambrosini, Ina Schmitt, Ullrich Wüllner, Naoki Osato, Philipp Bucher, Hongde Liu, Tikam Chand Dakal, Amit Sharma, Shailendra Asthana
Publikováno v:
Scientific reports 9(1), 18464 (2019). doi:10.1038/s41598-019-54865-w
Scientific Reports, Vol 9, Iss 1, Pp 1-9 (2019)
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-9 (2019)
Scientific Reports
Parkinson disease (PD) is characterized by a pivotal progressive loss of substantia nigra dopaminergic neurons and aggregation of α-synuclein protein encoded by the SNCA gene. Genome-wide association studies identified almost 100 sequence variants l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd6a32195c571ce4385be42c7fe9b66a
Publikováno v:
Scientific reports 9(1), 4857 (2019). doi:10.1038/s41598-019-41091-7
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-14 (2019)
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-14 (2019)
Dopamine (DA) release in striatum is functionally segregated across a dorsolateral/ventromedial axis. Interestingly, nigrostriatal DA signaling disruption in Parkinson’s disease (PD) preferentially affects the dorsolateral striatum. The relationshi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da83bd0ca67d4fefa1c3da2359e0f5f2
https://pub.dzne.de/record/140572
https://pub.dzne.de/record/140572